Here are the 10-Q quarterly reports from BLDEW (BLDEW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BLDEW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLDEW filings page.
Strata Critical Medical delivered strong growth and turned profitable in the quarter ended March 31, 2026. Revenue rose to $67.4 million from $35.9 million, driven by 32.4% growth in Logistics to $47.6 million and new Clinical revenue of $19.8 million from the Keystone acquisition.
Gross profit doubled to $14.1 million, lifting total gross margin to 21.0% as higher‑margin Clinical work scaled. After $5.4 million of other non‑operating income, mainly fair value changes, Strata posted net income of $2.2 million versus a $3.5 million loss a year earlier, including a small loss from discontinued Passenger operations.
The company ended the quarter with $58.7 million in cash and cash equivalents, total assets of $327.6 million and stockholders’ equity of $285.7 million. A new $30 million asset‑based revolving credit facility was put in place and remained undrawn, providing additional liquidity for working capital and growth.